-
Something wrong with this record ?
Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis
V. Melenovsky, J. Petrak, T. Mracek, J. Benes, BA. Borlaug, H. Nuskova, T. Pluhacek, J. Spatenka, J. Kovalcikova, Z. Drahota, J. Kautzner, J. Pirk, J. Houstek,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT14050
MZ0
CEP Register
NV16-27496A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2000-03-01 to 1 year ago
Wiley Free Content
from 1999 to 1 year ago
PubMed
27647766
DOI
10.1002/ejhf.640
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Myocardium metabolism MeSH
- Aged MeSH
- Mitochondria, Heart metabolism MeSH
- Heart Failure metabolism physiopathology surgery MeSH
- Case-Control Studies MeSH
- Heart Transplantation MeSH
- Iron metabolism MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIMS: Iron replacement improves clinical status in iron-deficient patients with heart failure (HF), but the pathophysiology is poorly understood. Iron is essential not only for erythropoiesis, but also for cellular bioenergetics. The impact of myocardial iron deficiency (MID) on mitochondrial function, measured directly in the failing human heart, is unknown. METHODS AND RESULTS: Left ventricular samples were obtained from 91 consecutive HF patients undergoing transplantation and 38 HF-free organ donors (controls). Total myocardial iron content, mitochondrial respiration, citric acid cycle and respiratory chain enzyme activities, respiratory chain components (complex I-V), and protein content of reactive oxygen species (ROS)-protective enzymes were measured in tissue homogenates to quantify mitochondrial function. Myocardial iron content was lower in HF compared with controls (156 ± 41 vs. 200 ± 38 µg·g-1 dry weight, P < 0.001), independently of anaemia. MID (the lowest iron tercile in HF) was associated with more extensive coronary disease and less beta-blocker usage compared with non-MID HF patients. Compared with controls, HF patients displayed reduced myocardial oxygen2 respiration and reduced activity of all examined mitochondrial enzymes (all P < 0.001). MID in HF was associated with preserved activity of respiratory chain enzymes but reduced activity of aconitase and citrate synthase (by -26% and -15%, P < 0.05) and reduced expression of catalase, glutathione peroxidase, and superoxide dismutase 2. CONCLUSION: Myocardial iron content is decreased and mitochondrial functions are impaired in advanced HF. MID in HF is associated with diminished citric acid cycle enzyme activities and decreased ROS-protecting enzymes. MID may contribute to altered myocardial substrate use and to worsening of mitochondrial dysfunction that exists in HF.
Department of Bioenergetics Institute of Physiology Academy of Sciences Prague Czech Republic
Department of Cardiovascular Diseases Mayo Clinic Rochester MN USA
Department of Transplantation and Tissue Bank University Hospital in Motol Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017033
- 003
- CZ-PrNML
- 005
- 20190920084608.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ejhf.640 $2 doi
- 035 __
- $a (PubMed)27647766
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Melenovský, Vojtěch $u Department of Cardiology and Cardiac Surgery, Institute of Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. $7 xx0160847
- 245 10
- $a Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis / $c V. Melenovsky, J. Petrak, T. Mracek, J. Benes, BA. Borlaug, H. Nuskova, T. Pluhacek, J. Spatenka, J. Kovalcikova, Z. Drahota, J. Kautzner, J. Pirk, J. Houstek,
- 520 9_
- $a AIMS: Iron replacement improves clinical status in iron-deficient patients with heart failure (HF), but the pathophysiology is poorly understood. Iron is essential not only for erythropoiesis, but also for cellular bioenergetics. The impact of myocardial iron deficiency (MID) on mitochondrial function, measured directly in the failing human heart, is unknown. METHODS AND RESULTS: Left ventricular samples were obtained from 91 consecutive HF patients undergoing transplantation and 38 HF-free organ donors (controls). Total myocardial iron content, mitochondrial respiration, citric acid cycle and respiratory chain enzyme activities, respiratory chain components (complex I-V), and protein content of reactive oxygen species (ROS)-protective enzymes were measured in tissue homogenates to quantify mitochondrial function. Myocardial iron content was lower in HF compared with controls (156 ± 41 vs. 200 ± 38 µg·g-1 dry weight, P < 0.001), independently of anaemia. MID (the lowest iron tercile in HF) was associated with more extensive coronary disease and less beta-blocker usage compared with non-MID HF patients. Compared with controls, HF patients displayed reduced myocardial oxygen2 respiration and reduced activity of all examined mitochondrial enzymes (all P < 0.001). MID in HF was associated with preserved activity of respiratory chain enzymes but reduced activity of aconitase and citrate synthase (by -26% and -15%, P < 0.05) and reduced expression of catalase, glutathione peroxidase, and superoxide dismutase 2. CONCLUSION: Myocardial iron content is decreased and mitochondrial functions are impaired in advanced HF. MID in HF is associated with diminished citric acid cycle enzyme activities and decreased ROS-protecting enzymes. MID may contribute to altered myocardial substrate use and to worsening of mitochondrial dysfunction that exists in HF.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x metabolismus $x patofyziologie $x chirurgie $7 D006333
- 650 _2
- $a transplantace srdce $7 D016027
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a železo $x metabolismus $7 D007501
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a srdeční mitochondrie $x metabolismus $7 D008929
- 650 _2
- $a myokard $x metabolismus $7 D009206
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Petrak, Jiri $u Department of Pathological Physiology and BIOCEV, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Mráček, Tomáš $u Department of Bioenergetics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic. $7 xx0122128
- 700 1_
- $a Beneš, Jan, $u Department of Cardiology and Cardiac Surgery, Institute of Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. $d 1983- $7 xx0221722
- 700 1_
- $a Borlaug, Barry A $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
- 700 1_
- $a Nuskova, Hana $u Department of Bioenergetics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Pluhacek, Tomas $u Department of Analytical Chemistry and RCPTM, Faculty of Science, Palacky University, Olomouc, Czech Republic.
- 700 1_
- $a Špatenka, Jaroslav, $u Department of Transplantation and Tissue Bank, University Hospital in Motol, Prague, Czech Republic. $d 1945- $7 jn20000402869
- 700 1_
- $a Kovalcikova, Jana $u Department of Bioenergetics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Drahota, Zdeněk, $u Department of Bioenergetics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic. $d 1932- $7 jn20000400531
- 700 1_
- $a Kautzner, Josef, $u Department of Cardiology and Cardiac Surgery, Institute of Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. $d 1957- $7 xx0037112
- 700 1_
- $a Pirk, Jan, $u Department of Cardiology and Cardiac Surgery, Institute of Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. $d 1948- $7 nlk19990073700
- 700 1_
- $a Houštěk, Josef, $u Department of Bioenergetics, Institute of Physiology, Academy of Sciences, Prague, Czech Republic. $d 1947- $7 xx0030591
- 773 0_
- $w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 19, č. 4 (2017), s. 522-530
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27647766 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20190920085000 $b ABA008
- 999 __
- $a ok $b bmc $g 1300657 $s 1013873
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 19 $c 4 $d 522-530 $e 20160919 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
- GRA __
- $a NT14050 $p MZ0
- GRA __
- $a NV16-27496A $p MZ0
- LZP __
- $a Pubmed-20180515